Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Possible link between androgens and COVID-19 severity; more research needed.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

COVID-19 can cause temporary hair loss.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Taking too much Albendazole can cause hair loss and other serious side effects.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

PHAT may improve hair growth better than PRP alone.

More people are searching for hair transplants online, preferring Follicular Unit Excision over Follicular Unit Transplant. There's also a rise in female patients and interest in beard, eyebrow transplants, and non-surgical treatments like platelet rich plasma.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.